Wikidata

(Q43680145)

English

An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis

scientific article published on 10 July 2009

In more languages

Statements

title
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017
author name string
Moutih Rafei
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017
Yamina A Berchiche
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017
Elena Birman
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017
Marie-Noëlle Boivin
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017
Yoon Kow Young
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017
Jian Hui Wu
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017
publication date
10 July 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017
page(s)
1759-1766
1 reference
stated in
Europe PubMed Central
PubMed ID
19592643
retrieved
25 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43680145&oldid=2102448602"